Inc. reported robust financial results for the fourth quarter of 2024, surpassing analysts' expectations with an earnings per share (EPS) of $2.31, slightly above the forecast of $2.30. The company's ...

Jan 28 (Reuters) - Zimmer Biomet (ZBH.N), opens new tab said on Tuesday it would acquire medical device company Paragon 28 (FNA.N), opens new tab for about $1.1 billion to expand its portfolio of ...

Zimmer Biomet to acquire Paragon 28 for $13/share, totaling $1.2B in enterprise value. Deal expected to close in H1 2025, with potential $1/share CVR based on 2026 sales milestones. Get the Real ...

Zimmer Biomet Holdings, Inc ... The recent FDA approval of OsseoFit Stemless Shoulder System for total shoulder replacement is expected to have contributed to the fourth-quarter top line.

Worth around $5 billion, the agreement broadens Zimmer Biomet's portfolio into the foot and ankle market. Depending on income targets, Paragon 28 shareholders will get $13 per share in cash under ...

Expected to Enhance Zimmer Biomet's Financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS within 24 Months of Deal Close WARSAW, Ind. and ENGLEWOOD, Colo., ...

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

(RTTNews) - Zimmer Biomet Holdings Inc. (ZBH) agreed to acquire all outstanding shares of common stock of Paragon 28 Inc. (FNA) for an upfront payment of $13.00 per share in cash, corresponding to ...

T Rowe Price Associates, Inc. (13F Subfiler) 7.12 Indices Commodities Currencies Stocks ...